Martin Schulz Email
Director and Head of Medical Alps (ChA) @ UCB
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Martin Schulz Location
- Zürich, ZH, CH
Martin Schulz Work
- 2026 -now Director and Head of Medical Alps (ChA) @
- 2023 -2026 Head of Medical Immunology @
- 2022 -2023 Head of Medical Oncology Italy (ad interim) @
- 2020 -2023 Head of Medical Oncology @
- 2015 -2020 Senior Medical Advisor Rheumatology @
- 2014 -2015 Medical Manager and Deputy Drug Safety Officer @ Astellas Pharma
- 2013 -2014 Medical Advisor and Deputy Drug Safety Officer @ Astellas Pharma
- 2012 -2013 Medical Advisor, Drug Safety Officer, Market Access Coordinator @ Astellas Pharma
- 2011 -2012 Postdoctoral Research Fellow @
- 2008 -2011 Research Assistant @ ETH, Swiss Federal Institute of Technology, Zurich
- 2007 -2007 Research assistant and Master student @
- 2006 -2006 Research intern @
- 2005 -2006 Research assistant @
- 2003 -2003 Research intern @
- 2002 -2003 Freelancer @ GATC Biotech
- 2002 -2002 Intern @ GATC Biotech
Martin Schulz Education
- University of Basel
Diploma of Advanced Studies (DAS) (Pharmaceutical Medicine (European Course of Pharmaceutical Medicine, ECPM))
2015-2017 - ETH Zürich
Dr. sc. (Pharmaceutical Sciences)
2008-2011 - Heidelberg University
Master of Sciences (MSc) (Molecular Biotechnology)
2002-2007 - Gymnasium Überlingen
High school graduation (Abitur)
1995-2001
Martin Schulz Skills
- Biowissenschaften
- Pharmaforschung
- High Content Screening
- High Throughput Screening
- Vascular Biology
- Drug Discovery
- Pharmaceutical Industry
- Pharmacovigilance
- Photography
- Lymphangiogenesis
- Medical Information
- Transplantation
- Statins
- Life Science
- Angiogenesis
- Oncology
- Anti-Infectives
- Candidiasis
- Clostridium difficile infection
- Stem cells
- Market Access
- Medical Affairs
- Non-Interventional Studies
- Rheumatology
- Pharmaindustrie
- Biochemistry
- Life Sciences
- Onkologie
- Biochemie
- Clostridium Difficile
- High Throughput
- Anti Infectives
- Non Interventional Studies
Martin Schulz Summary
- Martin Schulz, based in Zürich, ZH, CH, is currently a Director and Head of Medical Alps (ChA) at UCB. Martin Schulz brings experience from previous roles at AbbVie. Martin Schulz holds a 2015 - 2017 Diploma of Advanced Studies (DAS) in Pharmaceutical Medicine (European Course of Pharmaceutical Medicine, ECPM) @ University of Basel. With a robust skill set that includes Biowissenschaften, Pharmaforschung, High Content Screening, High Throughput Screening, Vascular Biology and more. Martin Schulz has 2 emails on RocketReach.
Looking for a different Martin Schulz?
Find contact details for 700 million professionals.
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co